MSH6 and non-small cell lung carcinoma: In this study, we investigated whether polymorphisms of MMR genes (MLH1, MSH2, MSH3, MSH4, MSH5, and MSH6) were associated with platinum-based chemotherapy toxicity in 220 NSCLC patients.